Catch pre-market movers with AI signals.
ADVM(Quitar la ciudad)
Adverum (ADVM) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Adverum market cap is -- and enterprise value is --.
Share Statistics
Adverum has 22.08M shares outstanding, with a free float of 11.44M.
Valuation Ratios
Adverum's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Adverum debt-to-equity ratio is 0 and debt-to-assets ratio is 1.77.
Liquidity
Adverum's current ratio is 0.65, quick ratio is 0.65, and cash ratio is 0.58, showing its short-term liquidity position.
Return on Capital
Adverum's ROE is -417.79%, ROA is -120.47%, and ROIC is -426.66%, showing its return on capital profile.
Profitability
Adverum gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
Adverum's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Adverum's revenue is --, gross profit is --, net income is -184.79M, and EBITDA is -187.91M.
Balance Sheet
Adverum's total debt is 0, net debt is 0, total equity is -55.65M, and cash is 26.06M.
Cash Flow Statement
Adverum's operating cash flow is -137.90M, free cash flow is -138.44M, and CapEx is -543.00K.
Dividends & Yields
Adverum dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Adverum's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage company that develops therapeutics based on novel gene therapies to treat ocular and rare diseases
Per Share Metrics
Adverum's EPS is -8.57, book value per share is -2.53, and free cash flow per share is --.
